Assessment of ABT-263 activity across a cancer cell line collection leads to a potent combination therapy for small-cell lung cancer
BH3 mimetics such as ABT-263 induce apoptosis in a subset of cancer models. However, these drugs have shown limited clinical efficacy as single agents in small-cell lung cancer (SCLC) and other solid tumor malignancies, and rational combination strategies remain underexplored. To develop a novel the...
প্রধান লেখক: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
অন্যান্য লেখক: | |
বিন্যাস: | প্রবন্ধ |
ভাষা: | en_US |
প্রকাশিত: |
National Academy of Sciences (U.S.)
2015
|
অনলাইন ব্যবহার করুন: | http://hdl.handle.net/1721.1/98407 https://orcid.org/0000-0001-5785-8911 |